Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
HIV / AIDS
Human papillomavirus (HPV)
Influenza
Adults
Clear all
Type of publications
Systematic reviews (SYSVAC)
(26)
Topics
Available to download in languages
Regions
Americas
(3)
Europe
(1)
South-East Asia
(1)
Countries
Diseases
HIV / AIDS
(1)
Human papillomavirus (HPV)
(21)
Influenza
(5)
COVID-19
(1)
Diphtheria
(1)
Hepatitis A
(1)
Hepatitis B
(2)
Herpes zoster
(6)
Measles
(2)
Meningococcal disease
(1)
Mumps
(2)
Pertussis
(1)
Pneumococcal disease
(5)
Rotavirus
(1)
Rubella
(2)
Tetanus
(1)
Varicella
(2)
Vaccine topics
Economic aspects
(26)
Acceptance
(74)
Administration
(40)
Coverage
(65)
Efficacy/effectiveness
(135)
Ethical issues
(9)
Logistics
(1)
Modeling
(2)
Safety
(68)
Target population
Adults
(26)
Adolescents
(28)
All age groups
(30)
Children
(3)
Healthcare workers
(7)
Newborn
(3)
Older adults
(11)
Parents/caregivers
(1)
Pregnant women
(5)
Publication date
2023
(2)
2022
(3)
2021
(2)
2020
(3)
2019
(3)
2018
(2)
2017
(3)
2016
(1)
2015
(2)
2014
(1)
2013
(1)
2012
(3)
26 results found
2019
∙
Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.
Cost-effectiveness of adult vaccinations: A systematic review
2019
∙
Kostaras, D. Karampli, E. Athanasakis, K.
Vaccination against HPV virus: a systematic review of economic evaluation studies for developed countries
2019
∙
Madeddu, G. Vroling, H. Oordt-Speets, A. Babudieri, S. O'Moore, E. Noordegraaf, M. V. Monarca, R. Lopalco, P. L. Hedrich, D. Tavoschi, L.
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries
2018
∙
Kopsaftis, Z. Wood-Baker, R. Poole, P.
Influenza vaccine for chronic obstructive pulmonary disease (COPD)
2018
∙
Ng, S. S. Hutubessy, R. Chaiyakunapruk, N.
Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination
2017
∙
Favato, G. Easton, T. Vecchiato, R. Noikokyris, E.
Ecological validity of cost-effectiveness models of universal HPV vaccination: A systematic literature review
2017
∙
Gervais, F. Dunton, K. Jiang, YiLing Largeron, N.
Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend
2017
∙
Setiawan, D. Oktora, M. P. Hutubessy, R. Riewpaiboon, A. Postma, M. J.
The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review
2016
∙
Angioli, R. Lopez, S. Aloisi, A. Terranova, C. De Cicco, C. Scaletta, G. Capriglione, S. Miranda, A. Luvero, D. Ricciardi, R. Montera, R. Plotti, F.
Ten years of HPV vaccines: State of art and controversies
2015
∙
Ben Hadj Yahia, M. B. Jouin-Bortolotti, A. Dervaux, B.
Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register